D J Brambilla
Overview
Explore the profile of D J Brambilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
2168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gehrie E, Roubinian N, Chowdhury D, Brambilla D, Murphy E, Gottschall J, et al.
Vox Sang
. 2017 Dec;
113(2):160-169.
PMID: 29277907
Background And Objectives: Many hospitals require transfusions to be discontinued when vital signs stray from predetermined ranges, regardless of clinical symptoms. Variations in vital signs may be unrelated to transfusion,...
2.
Ragni M, Machin N, Malec L, James A, Kessler C, Konkle B, et al.
Haemophilia
. 2016 Feb;
22(3):397-402.
PMID: 26843404
Background: von Willebrand disease (VWD) is the most common congenital bleeding disorder. In women, menorrhagia is the most common bleeding symptom, and is disabling with iron deficiency anaemia, high health...
3.
Ragni M, Ojeifo O, Feng J, Yan J, Hill K, Sommer S, et al.
Haemophilia
. 2009 Jul;
15(5):1074-82.
PMID: 19563499
Inhibitor formation is a major complication of haemophilia treatment. In a prevalent case-control study, we evaluated blood product exposure, genotype and HLA type on haemophilia A inhibitor formation. Product exposure...
4.
Ragni M, Journeycake J, Brambilla D
Haemophilia
. 2007 Nov;
14(1):30-8.
PMID: 18005145
The recent unequivocal demonstration that prophylaxis, three to four weekly factor infusions, is effective in preventing joint disease in children with haemophilia, has provided impetus to initiate prophylaxis early in...
5.
Brambilla D, Granger S, Jennings C, Bremer J
J Clin Microbiol
. 2001 Mar;
39(3):1121-3.
PMID: 11230438
Reproducibility and recovery from the standard and ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits were compared in 19 laboratories. The results were generally similar, but the consistently low level of recovery...
6.
Brambilla D, Granger S, Jennings C, Bremer J
J Clin Microbiol
. 2001 Mar;
39(3):1118-20.
PMID: 11230437
Specifications for the AMPLICOR HIV-1 MONITOR kit indicate that the results are invalid if the optical densities (ODs) from the PCR-amplified sample that are between 0.1 and 2.3 units are...
7.
Jennings C, Bremer J, Brambilla D
J Clin Microbiol
. 2001 Feb;
38(9):3522.
PMID: 11203333
No abstract available.
8.
Kruskall M, Aubuchon J, Anthony K, Herschel L, Pickard C, Biehl R, et al.
Transfusion
. 2000 Dec;
40(11):1290-8.
PMID: 11099655
Background: The transfusion of ABO-incompatible RBCs is the leading cause of fatal transfusion reactions. Group O RBCs, lacking terminal immunodominant A and B sugars to which humans are immunized, are...
9.
Brambilla D, McKinlay S, McKinlay J, Weiss S, Johannes C, Crawford S, et al.
J Clin Epidemiol
. 1996 Mar;
49(3):345-50.
PMID: 8676183
Measuring levels of steroid hormones in epidemiologic studies is difficult because pulsatile release can cause the levels of many hormones to vary markedly over short intervals, leading to a loss...
10.
Brambilla D, McKinlay S, Johannes C
Am J Epidemiol
. 1994 Dec;
140(12):1091-5.
PMID: 7998591
The authors present a method for defining the inception of perimenopause that is based on self-reported data. The study sample (n = 1,550) was obtained from a 5-year longitudinal study...